"I really feel that the treatment of gout as well as asymptomatic hyperuricemia ... should be a team-based approach. We need to incorporate the primary care physician who's often going to be that person getting the call for an acute flare on the nights or weekends. But we also have to include the rheumatologists because a lot of our guidelines come from their societies. And certainly, the nephrologists because the impact that uric acid has on the skeletal system as well as the kidneys is very important."
In this video, Monica Richey, MSN, ANP-BC/GNP, discusses common comorbidies among patients with chronic gout, the role of comorbidies in treatment options for patients with chronic gout, and a case...
In this video, Monica Richey, MSN, ANP-BC/GNP, discusses the agents that are available in the management of patients with gout, the possible challenges and complications clinicians should consider in...
In this video, Robert Terkeltaub, MD, discusses his team's latest research on the pathophysiology of gout and a potential pathway for treatment by way of a molecule called lubricin in patients with gout who...
Up to 40% of individuals with IBD may experience extraintestinal manifestations of the disease. Are you familiar with the common extraintestinal manifestations among these patients? Take the pop quiz to...
Recent research may suggest that a combination of personalized treatment plus education about gout results in better treatment adherence rates in the long term. Do you agree?
The American College of Rheumatology Guideline for the Management of Gout recommends urate-lowering therapy (ULT) as first-line therapy for patients with gout. Do you know which specific therapeutic agent...
In this video, Monica Richey, MSN, ANP-BC/GNP, discusses common comorbidies among patients with chronic gout, the role of comorbidies in treatment options for patients with chronic gout, and a case...
In this video, Monica Richey, MSN, ANP-BC/GNP, discusses the agents that are available in the management of patients with gout, the possible challenges and complications clinicians should consider in...
In this video, Robert Terkeltaub, MD, discusses his team's latest research on the pathophysiology of gout and a potential pathway for treatment by way of a molecule called lubricin in patients with gout who...
In this video, James Matera, DO, discusses hyperuricemia vs gout, recent studies on the role of lubricin in patients with gout, and a case presentation of a 76-year-old woman with significant hyperuricemia,...
In this video, Robert Terkeltaub, MD, discusses classifying gout as acute or chronic, and how treatment should be tailored for each patient based on disease severity and characteristics as well as other...
